Inventor
GRANGER BRETT
US30 patents
Patents
30 patentsUS10683279B2Jun 16, 2020
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC13 citations94
US11560368B2Jan 24, 2023
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC6 citations86
US11420976B2Aug 23, 2022
Heterocyclic compounds as anti-viral agents
ENANTA PHARM INC7 citations86
US10988458B2Apr 27, 2021
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC7 citations84
US10683289B2Jun 16, 2020
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC10 citations84
US10676500B2Jun 9, 2020
Process for preparation of sulfonyl carbamate bile acid derivatives
ENANTA PHARM INC7 citations84
US10597382B2Mar 24, 2020
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC10 citations84
US10457703B2Oct 29, 2019
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC8 citations84
US10450301B2Oct 22, 2019
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC11 citations84
US10253018B2Apr 9, 2019
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC10 citations84
US10246439B2Apr 2, 2019
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC12 citations84
US12018017B2Jun 25, 2024
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC1 citations73
US11958879B2Apr 16, 2024
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC1 citations73
US11834436B2Dec 5, 2023
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC2 citations73
US11040998B2Jun 22, 2021
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC2 citations73
US10472386B2Nov 12, 2019
Bile acid derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC6 citations73
US10149835B2Dec 11, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC2 citations73
US10080741B2Sep 25, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US10080743B2Sep 25, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC4 citations73
US10080742B2Sep 25, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US12552777B2Feb 17, 2026
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations63
US12459923B2Nov 4, 2025
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations63
US11008304B2May 18, 2021
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC1 citations63
US10144729B2Dec 4, 2018
Isoxazole analogs as FXR agonists and methods of use thereof
ENANTA PHARM INC2 citations63
US10961272B2Mar 30, 2021
Process for preparation of sulfonyl carbamate bile acid derivatives
ENANTA PHARM INC0 citations62
US11466033B2Oct 11, 2022
Substituted pyridines as apoptosis signal-regulating kinase 1 inhibitors
ENANTA PHARM INC0 citations52
US11345699B2May 31, 2022
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations52
US10968199B2Apr 6, 2021
Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations52
US10138228B2Nov 27, 2018
Isoxazole derivatives as FXR agonists and methods of use therof
ENANTA PHARM INC1 citations52
US12384753B2Aug 12, 2025
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations50